Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ostor, Andrew J
176  Ergebnisse:
Personensuche X
?
1

Impact of a Patient Support Program on time to discontinuat..:

Jones, Graeme ; Calao, Miriam ; Begun, Jakob...
PLOS ONE.  19 (2024)  6 - p. e0300624 , 2024
Link: https://doi.org/10.1371/..
 
?
2

Efficacy and Safety of Risankizumab for Active Psoriatic Ar..:

Östör, Andrew ; Van den Bosch, Filip ; Papp, Kim...
Rheumatology and Therapy.  11 (2024)  3 - p. 633-648 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Effect of Upadacitinib on Disease Activity, Pain, Fatigue, ..:

Navarro-Compán, Victoria ; Baraliakos, Xenofon ; Magrey, Marina...
Rheumatology and Therapy.  10 (2023)  3 - p. 679-691 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Comparative Effectiveness, Time to Discontinuation, and Pat..:

Alten, Rieke ; Burmester, Gerd R. ; Matucci-Cerinic, Marco...
Rheumatology and Therapy.  10 (2023)  6 - p. 1575-1595 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Efficacy and safety of upadacitinib in patients with active..:

Baraliakos, Xenofon ; Ranza, Roberto ; Östör, Andrew...
Arthritis Research & Therapy.  25 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
6

What is new in pharmacological treatment for osteoarthritis:

Gezer, Halise Hande ; Ostor, Andrew
Best Practice & Research Clinical Rheumatology.  37 (2023)  2 - p. 101841 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Efficacy and Safety of the TYK2/JAK1 Inhibitor Brepocitinib..:

Mease, Philip ; Helliwell, Philip ; Silwinska‐Stanczyk, Paula...
Arthritis & Rheumatology.  75 (2023)  8 - p. 1370-1380 , 2023
Link: https://doi.org/10.1002/..
 
?
8

Correction: Clinical and Economic Benefit of Advanced Thera..:

Walsh, Jessica A. ; Saffore, Christopher D. ; Collins, Eric B..
Rheumatology and Therapy.  11 (2023)  1 - p. 225-226 , 2023
Link: https://doi.org/10.1007/..
 
?
9

P134 Efficacy of Upadacitinib on Psoriatic Arthritis with A..:

Baraliakos, Xenofon ; Ranza, Roberto ; Ostor, Andrew...
Rheumatology.  62 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
10

Clinical and Economic Benefit of Advanced Therapies for the..:

Walsh, Jessica A. ; Saffore, Christopher D. ; Collins, Eric B..
Rheumatology and Therapy.  10 (2023)  5 - p. 1385-1398 , 2023
Link: https://doi.org/10.1007/..
 
?
11

43944 Improvements in Manifestations of Active Psoriatic Ar..:

Strober, Bruce ; Kivitz, Alan ; Östör, Andrew...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB179 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Maintenance of Response to Risankizumab in Patients With Ps..:

Ostor, Andrew ; Chen, Michael ; Padilla, Byron...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  6 - p. s249 , 2023
Link: https://doi.org/10.25251..
 
?
13

P131 Time to Discontinuation and Effectiveness with Baricit..:

Alten, Rieke ; Burmester, Gerd R ; Matucci-Cerinic, Marco...
Rheumatology.  62 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
14

33065 Effects of treatment with risankizumab on reducing pa..:

Ostor, Andrew ; Kwatra, Shawn ; Nduaka, Chudi
Journal of the American Academy of Dermatology.  87 (2022)  3 - p. AB49 , 2022
Link: https://doi.org/10.1016/..
 
?
15

OA38 Efficacy and safety of upadacitinib in patients with p..:

Deodhar, Atul ; Ranza, Roberto ; Ganz, Fabiana...
Rheumatology.  61 (2022)  Supplement_1 - p. , 2022
Link: https://doi.org/10.1093/..
 
1-15